
Sign up to save your podcasts
Or
輝瑞/BNT第三期臨床試驗追蹤了六個月後的結果。
每兩個月,保護力從96.2%降到90.1%降到83.7%但對重症的防護力都維持得非常好。
這要怎麼解讀?請聽這集!
Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine
https://www.medrxiv.org/content/10.1101/2021.07.28.21261159v1
Efficacy of Pfizer/BioNTech Covid vaccine slips to 84% after six months (statnews.com)
https://www.statnews.com/2021/07/28/efficacy-of-pfizer-biontech-covid-vaccine-slips-to-84-after-six-months-data-show/
給長輩的AZ疫苗懶人包
https://linshibi.com/?p=39590
高端 聯亞 國產疫苗懶人包 第二期結束就緊急授權可行嗎?
https://linshibi.com/?p=39547
新冠快篩懶人包 普篩 抗體快篩 抗原快篩
https://linshibi.com/?p=36564
新冠肺炎疫情下的防疫須知 常見問題解答FAQ
https://linshibi.com/?p=35408
新冠疫苗常見問題懶人包
https://linshibi.com/?p=38945
林氏璧醫師的電子名片
https://lit.link/linshibi
歡迎贊助我喝咖啡
https://open.firstory.me/join/linshibi
4.8
107107 ratings
輝瑞/BNT第三期臨床試驗追蹤了六個月後的結果。
每兩個月,保護力從96.2%降到90.1%降到83.7%但對重症的防護力都維持得非常好。
這要怎麼解讀?請聽這集!
Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine
https://www.medrxiv.org/content/10.1101/2021.07.28.21261159v1
Efficacy of Pfizer/BioNTech Covid vaccine slips to 84% after six months (statnews.com)
https://www.statnews.com/2021/07/28/efficacy-of-pfizer-biontech-covid-vaccine-slips-to-84-after-six-months-data-show/
給長輩的AZ疫苗懶人包
https://linshibi.com/?p=39590
高端 聯亞 國產疫苗懶人包 第二期結束就緊急授權可行嗎?
https://linshibi.com/?p=39547
新冠快篩懶人包 普篩 抗體快篩 抗原快篩
https://linshibi.com/?p=36564
新冠肺炎疫情下的防疫須知 常見問題解答FAQ
https://linshibi.com/?p=35408
新冠疫苗常見問題懶人包
https://linshibi.com/?p=38945
林氏璧醫師的電子名片
https://lit.link/linshibi
歡迎贊助我喝咖啡
https://open.firstory.me/join/linshibi
150 Listeners
78 Listeners
310 Listeners
42 Listeners
40 Listeners
23 Listeners
456 Listeners
4 Listeners
8 Listeners
13 Listeners
9 Listeners
179 Listeners
4 Listeners
9 Listeners
52 Listeners